I agree that this site is using cookies. You can find further informations here.
X
Warnock, David G
925  results:
Search for persons X
?
1

Response to commentary: Head-to-head trial of pegunigalsida..:

Warnock, David G ; Wallace, Eric L
Journal of Medical Genetics.  , 2024
Link: https://doi.org/10.1136/..
 
?
2

Assessment of immunogenicity from the pegunigalsidase alfa ..:

Bernat, John ; Hughes, Derralynn ; Linhart, Aleš...
Molecular Genetics and Metabolism.  141 (2024)  2 - p. 107771 , 2024
Link: https://doi.org/10.1016/..
 
?
3

First results of a head-to-head trial of pegunigalsidase al..:

Wallace, Eric ; Goker-Alpan, Wilcox ; Holida, Bernat...
Molecular Genetics and Metabolism.  138 (2023)  2 - p. 107351 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Risk Factors for Incident CKD in Black and White Americans:..:

Cheung, Katharine L. ; Crews, Deidra C. ; Cushman, Mary...
American Journal of Kidney Diseases.  82 (2023)  1 - p. 11-21.e1 , 2023
Link: https://doi.org/10.1053/..
 
?
5

Estimation of arrhythmia risk in patients with Fabry diseas..:

Aguiar, Patricio ; Biondetti, Giorgio Pietro ; Warnock, David G....
Molecular Genetics and Metabolism.  138 (2023)  2 - p. 106992 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Long-term safety and efficacy of pegunigalsidase alfa admin..:

Bernat, John ; Holida, Myrl D. ; Longo, Nicola...
Molecular Genetics and Metabolism.  138 (2023)  2 - p. 107027 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Estimation of stroke risk in patients with Fabry disease us..:

Kallish, Staci ; Biondetti, Giorgio Pietro ; Jefferies, John L....
Molecular Genetics and Metabolism.  138 (2023)  2 - p. 107175 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Elucidating the toxic effect and disease mechanisms associa..:

Nikolaenko, Valeria ; Warnock, David G ; Mills, Kevin.
Human Molecular Genetics.  32 (2023)  15 - p. 2464-2472 , 2023
Link: https://doi.org/10.1093/..
 
?
9

Understanding and modifying Fabry disease: Rationale and de..:

Wanner, Christoph ; Kimonis, Virginia ; Politei, Juan...
Molecular Genetics and Metabolism Reports.  31 (2022)  - p. 100862 , 2022
Link: https://doi.org/10.1016/..
 
?
10

A new approach to identifying patients with elevated risk f..:

Jefferies, John L. ; Spencer, Alison K. ; Lau, Heather A....
Orphanet Journal of Rare Diseases.  16 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
11

Utilization of artificial intelligence to identify undiagno..:

Jefferies, John L. ; Spencer, Alison K. ; Warnock, David G....
Molecular Genetics and Metabolism.  132 (2021)  2 - p. S52 , 2021
Link: https://doi.org/10.1016/..
 
?
12

Lyso-Gb3 associates with adverse long-term outcome in patie..:

Nowak, Albina ; Beuschlein, Felix ; Sivasubramaniam, Visnuka..
Journal of Medical Genetics.  59 (2021)  3 - p. 287-293 , 2021
Link: https://doi.org/10.1136/..
 
?
13

Use of a rare disease registry for establishing phenotypic ..:

Germain, Dominique P ; Oliveira, João Paulo ; Bichet, Daniel G...
Journal of Medical Genetics.  57 (2020)  8 - p. 542-551 , 2020
Link: https://doi.org/10.1136/..
 
?
14

Early indicators of disease progression in Fabry disease th..:

Hughes, Derralynn A ; Aguiar, Patricio ; Deegan, Patrick B...
BMJ Open.  10 (2020)  10 - p. e035182 , 2020
Link: https://doi.org/10.1136/..
 
?
15

Current and Investigational Therapeutics for Fabry Disease:

Felis, Andrew ; Whitlow, Michael ; Kraus, Abigayle..
Kidney International Reports.  5 (2020)  4 - p. 407-413 , 2020
Link: https://doi.org/10.1016/..
 
1-15